OCT biomarkers as predictors of treatment interval in neovascular age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen

Key Points

• Treatment intervals are influenced by specific OCT biomarkers, impacting long-term outcomes.
• Key OCT biomarker findings include retinal fluid and thickness measurements to guide therapy decisions.
• Analysis of treatment intervals was based on patients receiving intravitreal aflibercept on a treat-and-extend regimen.
• These findings highlight the potential for personalized treatment approaches based on OCT assessments.